Fig. 4

Immunodetection of FAS, cFLIP, PARP, cleaved PARP and β-actin following exposure to the protein synthesis inhibitor CHX (0.25 μg/mL) and FasAb (1 μg/mL) in KGN cells. a Representative immunoblot of FAS, cFLIP, PARP, cleaved PARP and β-actin following treatments; b Relative expression of FAS normalized to β-actin (means ± SEM) following treatment; c Relative expression of cFLIP normalized to β-actin (means ± SEM) following treatment; d Relative expression of cleaved PARP normalized to β-actin (Means ± SEM) following treatment. (n = 3 experiments, different letters denote differences, P < 0.05)